EBS
Emergent BioSolutions Inc
Price:  
12.02 
USD
Volume:  
3,403,391.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS EV/EBITDA

-609.2%
Upside

As of 2024-07-18, the EV/EBITDA ratio of Emergent BioSolutions Inc (EBS) is -7.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EBS's latest enterprise value is 1,457.25 mil USD. EBS's TTM EBITDA according to its financial statements is -202.10 mil USD. Dividing these 2 quantities gives us the above EBS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.7x - 13.5x 12.1x
Forward P/E multiples 9.4x - 13.5x 11.4x
Fair Price (57.06) - (67.86) (61.20)
Upside -574.7% - -664.5% -609.2%
12.02 USD
Stock Price
(61.20) USD
Fair Price

EBS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-17 -7.21
2024-07-16 -7.23
2024-07-15 -7.03
2024-07-12 -6.86
2024-07-11 -6.66
2024-07-10 -6.51
2024-07-09 -6.35
2024-07-08 -6.20
2024-07-05 -6.15
2024-07-03 -6.05
2024-07-02 -6.04
2024-07-01 -5.92
2024-06-28 -5.86
2024-06-27 -5.90
2024-06-26 -5.79
2024-06-25 -5.88
2024-06-24 -5.85
2024-06-21 -5.78
2024-06-20 -5.77
2024-06-18 -5.67
2024-06-17 -5.65
2024-06-14 -5.69
2024-06-13 -5.66
2024-06-12 -5.73
2024-06-11 -5.77
2024-06-10 -5.75
2024-06-07 -5.70
2024-06-06 -5.72
2024-06-05 -5.82
2024-06-04 -5.54
2024-06-03 -5.68
2024-05-31 -5.57
2024-05-30 -5.41
2024-05-29 -5.30
2024-05-28 -5.32
2024-05-24 -5.33
2024-05-23 -5.37
2024-05-22 -5.40
2024-05-21 -5.44
2024-05-20 -5.60
2024-05-17 -5.53
2024-05-16 -5.46
2024-05-15 -5.57
2024-05-14 -5.41
2024-05-13 -5.48
2024-05-10 -5.22
2024-05-09 -5.23
2024-05-08 -5.24
2024-05-07 -5.23
2024-05-06 -5.13